Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Innate Pharma - Filing #2813423

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
68 033 EUR
129 241 EUR
Current assets
139 831 EUR
138 256 EUR
Non-current liabilities
112 374 EUR
80 169 EUR
Current liabilities
41 338 EUR
79 886 EUR
Revenue
57 674 EUR
24 703 EUR
Profit (loss) from continuing operations
57 972 EUR
45 478 EUR
Profit (loss) from discontinued operations
131,000 EUR
7 331 EUR
Profit (loss)
EUR
EUR
58 103 EUR
EUR
58 103 EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
52 809 EUR
EUR
EUR
52 809 EUR
Other comprehensive income
362,000 EUR
101,000 EUR
Comprehensive income
EUR
362,000 EUR
57 741 EUR
EUR
58 103 EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
52 809 EUR
101,000 EUR
EUR
52 708 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.